Rescue therapy after thrombectomy for large vessel occlusion due to underlying atherosclerosis: review of literature

医学 血管成形术 狭窄 气球 闭塞 替罗非班 冲程(发动机) 心脏病学 外科 内科学 心肌梗塞 传统PCI 机械工程 工程类
作者
Tigran Khachatryan,Mohammad Shafie,Hermelinda Abcede,Jay Shah,Masaki Nagamine,Justin H. Granstein,Ichiro Yuki,Kiarash Golshani,Shinichi Suzuki,Wengui Yu
出处
期刊:Frontiers in Neurology [Frontiers Media SA]
卷期号:14
标识
DOI:10.3389/fneur.2023.1181295
摘要

In this review article, we summarized the current advances in rescue management for reperfusion therapy of acute ischemic stroke from large vessel occlusion due to underlying intracranial atherosclerotic stenosis (ICAS). It is estimated that 24-47% of patients with acute vertebrobasilar artery occlusion have underlying ICAS and superimposed in situ thrombosis. These patients have been found to have longer procedure times, lower recanalization rates, higher rates of reocclusion and lower rates of favorable outcomes than patients with embolic occlusion. Here, we discuss the most recent literature regarding the use of glycoprotein IIb/IIIa inhibitors, angioplasty alone, or angioplasty with stenting for rescue therapy in the setting of failed recanalization or instant/imminent reocclusion during thrombectomy. We also present a case of rescue therapy post intravenous tPA and thrombectomy with intra-arterial tirofiban and balloon angioplasty followed by oral dual antiplatelet therapy in a patient with dominant vertebral artery occlusion due to ICAS. Based on the available literature data, we conclude that glycoprotein IIb/IIIa is a reasonably safe and effective rescue therapy for patients who have had a failed thrombectomy or have residual severe intracranial stenosis. Balloon angioplasty and/or stenting may be helpful as a rescue treatment for patients who have had a failed thrombectomy or are at risk of reocclusion. The effectiveness of immediate stenting for residual stenosis after successful thrombectomy is still uncertain. Rescue therapy does not appear to increase the risk of sICH. Randomized controlled trials are warranted to prove the efficacy of rescue therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斑鸠津完成签到,获得积分10
刚刚
wang0626完成签到 ,获得积分10
1秒前
康琦琦完成签到 ,获得积分10
3秒前
huanhuan完成签到,获得积分10
3秒前
3秒前
arisfield完成签到,获得积分10
4秒前
baoxiaozhai完成签到 ,获得积分10
4秒前
嘻嘻哈哈啊完成签到 ,获得积分10
6秒前
三人水明完成签到 ,获得积分10
10秒前
芮安的白丁完成签到 ,获得积分10
10秒前
dominate完成签到,获得积分10
10秒前
10秒前
隐形曼青应助科研通管家采纳,获得10
10秒前
吱吱吱完成签到 ,获得积分10
11秒前
温暖大米完成签到 ,获得积分10
12秒前
科研通AI2S应助centlay采纳,获得10
12秒前
寒冷的迎梦完成签到,获得积分10
12秒前
东十八完成签到 ,获得积分10
13秒前
123456完成签到,获得积分10
14秒前
zuo完成签到,获得积分10
14秒前
double完成签到,获得积分10
15秒前
wang完成签到 ,获得积分10
16秒前
努力发文的医学僧完成签到,获得积分10
17秒前
st89225完成签到,获得积分10
18秒前
adamchris完成签到,获得积分10
20秒前
763完成签到 ,获得积分10
20秒前
研友_8KXkJL完成签到 ,获得积分10
21秒前
李L完成签到,获得积分10
22秒前
22秒前
研友_8oYg4n完成签到,获得积分10
22秒前
小单王完成签到,获得积分10
23秒前
Eureka完成签到 ,获得积分10
23秒前
yuan完成签到,获得积分10
25秒前
卤西瓜的科研蛋完成签到,获得积分10
25秒前
XIeXIe完成签到,获得积分10
26秒前
26秒前
DrW完成签到,获得积分10
29秒前
许望完成签到,获得积分10
29秒前
搜集达人应助wanghe采纳,获得10
30秒前
我不困完成签到,获得积分10
31秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
叶剑英与华南分局档案史料 500
Foreign Policy of the French Second Empire: A Bibliography 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3146969
求助须知:如何正确求助?哪些是违规求助? 2798221
关于积分的说明 7827159
捐赠科研通 2454808
什么是DOI,文献DOI怎么找? 1306480
科研通“疑难数据库(出版商)”最低求助积分说明 627788
版权声明 601565